According to a market report, published by Sheer Analytics and Insights, the total global stem cells market was valued at $ 16.2 billion in 2021 and it is expected to reach $50.7 billion at a CAGR of 10.70% through the forecast period 2022 and 2032. Adoption of stem cells is increasing due to the treatment of several diseases such as genetic and non-genetic diseases, which is expected to fuel the market growth during the forecast period. For instance, a couple of years ago, Personalized Stem Cells, Inc. an investigative new drug application has been submitted to U.S FDA for patients to use stem cells derived from their adipose for the treatment of osteoarthritis. However, stem cells are obtained from human cells. Stem cells therapy is also known as regenerative medicine, which can regenerate cells, tissues, and organs from humans to reinstate the general functioning of the body. Moreover, stem cells therapy is widely used in the treatment of the human body diseases such as Parkinson’s disease, diabetes, heart disease, spinal cord injury, and sickle cells disease. Few companies are getting some strong funding to develop cellular therapies for chronic diseases such as cancer, which is estimated to fuel the market growth through the upcoming periods.
Request a Sample Copy of Report: https://www.sheeranalyticsandinsights.com/request-sample/stem-cells-market-21
Few key players in the stem cells market are trying to focus on developing innovative new technologies such as Induced Pluripotent Stem Cells to increase the efficiency of stem cells therapies. Induced Pluripotent Stem Cells derived from blood cells, reprogram an embryonic pluripotent state by absorbing genes which are very important for maintaining major properties and growth of the ultimate source of any type of human cells which is required for stem cells therapeutics purposes. For example, two Japanese companies such as Oksara and Takara Bio Company have launched a medical center for producing cells that would be obtained from Induced Pluripotent Stem Cells. In the U.S country, the Food and Drug Administration’s Center for Biologics Evaluation and Research has become the major regulator for cells, tissues, and cellular of humans.
At present days, regenerative medicines are increasing, which is further driving the growth of the market. Induce Pluripotent Stem Cells are rising in popularity for the development of personalized cellular therapies are making new opportunities for regenerative medicine in various regions. Furthermore, the adoption of stem cells in R&D activities is expected to boost the market growth in the upcoming years. However, in several countries government has imposed regulation acts against deceitful harvesting of stem cells from the human body, which are expected to hamper the growth of the global market.
According to the study, key players dominating the global stem cell market are Celgene Pharmaceutical Company (U.S), Reneuron Group Biotechnology Company (U.K), Virgin Group Multinational Conglomerate Company (U.K), Biovault Family Limited (U.K), Precious Cells International Limited (Scotland), Opexa Therapeutics Biotechnology Company (U.S), Pluristem Therapeutics Company (Israel), Stemcell Technologies Company (Canada), ThermoGenesis Holdings Commercial Company (U.S), Astellas Pharma Pharmaceutical Company (Japan), Lineage Cell Therapeutics Biotechnology Company (U.S), Mesoblast Company (Australia), Athersys Biotechnology Company (U.S), Cryo-Cell International Company (U.S), Geron Corporation Biotechnology Company (U.S), Verical Company (U.S), Bristol Myers Squibb Pharmaceutical Industry Company (U.S), Merck Group Chemicals Company (Germany), BD Medical Device Company (U.S), Thermo Fisher Scientific Corporation (U.S), Plus Therapeutics Company (U.S), LifeCell International Private Limited (India), StemCyte India Therapeutics Private Limited (India), Reelabs Private Limited (India), Stempeutics Research Private Limited (India), among others.
The Global Stem Cells Market Has Been Segmented Into:
The Global Stem Cells Market – by Stem Cells Product Type:
- Adult Stem Cells
- Human Embryonic Stem Cells
- Induce Pluripotent Stem Cells
- Very Small Embryonic Stem Cells
The Global Stem Cells Market – by Applications Type:
- Regenerative Medicines
- Drug Discovery and Other Developments
The Global Stem Cells Market – by Technology Type:
- Cell Acquisition
- Cell Production
- Cryopreservation
- Expansion and Sub-Culture
The Global Stem Cells Market – by End-User:
- Therapeutics Companies
- Cell and Tissue Banks
- Services Companies
- Tools and Reagents Companies
The Global Stem Cells Market – by Regions:
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- Italy
- U.K.
- Russia
- Rest of Europe Countries
Asia-Pacific
- India
- China
- Japan
- South Korea
- North Korea
- Rest of Asian Countries
Latin America, Middle East & Africa (LAMEA)
- Brazil
- Saudi Arabia
- Rest of LAMEA
Browse The Full Report at https://www.sheeranalyticsandinsights.com/market-report-research/stem-cells-market-21
About Us
Sheer Analytics and Insights Private Limited is market research, consulting, and IT services company. We as a company believe in providing point to point data and its analysis with the combination of our human and automation integration. Sheer Analytics and Insights cover majorly eight industry verticals, including chemicals, life science, communications, and electronics, materials, consumer goods, defense, and BFSI sector.
Sheer Analytics believes in quality work and ensures that the product delivered to the client is meaningful for them. We publish reports based on our advanced analytics reports, which are generated with the help of our in-house databases, external databases, and artificial intelligence integration processes. We stand out from other market research companies in terms of integrating facts with meaningful insights for forecasting.
Contact:
Abhigyan Sengupta
Sheer Analytics and Insights
Email: query@sheeranalyticsandinsights.com
+1-414-240-5010
No comments:
Post a Comment